Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group. [electronic resource]
Producer: 19990421Description: 1207-16 p. digitalISSN:- 0269-2813
- Adolescent
- Adult
- Aged
- Aminosalicylic Acids -- administration & dosage
- Anti-Ulcer Agents -- therapeutic use
- Colitis, Ulcerative -- drug therapy
- Delayed-Action Preparations -- pharmacokinetics
- Double-Blind Method
- Female
- Headache -- chemically induced
- Humans
- Male
- Mesalamine -- administration & dosage
- Middle Aged
- Phenylhydrazines
- Secondary Prevention
- Time Factors
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.